Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Other Non-Current Assets data on file, last reported at $517000.0 in Q1 2026.

• Quarterly Other Non-Current Assets fell 32.68% year-over-year to $517000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $517000.0 (down 32.68% YoY) and the FY2025 annual result came in at $768000.0, up 48.26% from the prior year.
• Other Non-Current Assets fell to $517000.0 in Q1 2026, from $768000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $893000.0 in Q2 2022 to a low of $125000.0 in Q1 2022.
• A 5-year average of $687764.7 and a median of $768000.0 in 2022 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 614.4% — and 2026, when it tumbled 32.68%.
• Tracing AURA's Other Non-Current Assets over 5 years: stood at $423000.0 in 2022, then jumped by 81.56% to $768000.0 in 2023, then sank by 32.55% to $518000.0 in 2024, then jumped by 48.26% to $768000.0 in 2025, then sank by 32.68% to $517000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $517000.0 (Q1 2026), $768000.0 (Q4 2025), and $768000.0 (Q3 2025), per Business Quant data.